Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

NCT00807755 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Number of known toxicities observed despite a treatment-naïve population

Conditions

Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: Carboplatin
DRUG: Etoposide
DRUG: RAD001

Sponsor

University of California, Davis

Collaborators

[object Object]